Strata Skin Sciences (SSKN)
(Delayed Data from NSDQ)
$1.91 USD
-0.04 (-2.05%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $1.92 +0.01 (0.52%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SSKN 1.91 -0.04(-2.05%)
Will SSKN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SSKN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SSKN
Why Fast-paced Mover Strata Skin Sciences (SSKN) Is a Great Choice for Value Investors
Despite Fast-paced Momentum, Strata Skin Sciences (SSKN) Is Still a Bargain Stock
SSKN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SSKN
STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and ...
12 Health Care Stocks Moving In Tuesday's After-Market Session
Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Ionis Pharmaceuticals (IONS) and Maze Therapeutics, Inc. (MAZE)
SSKN Gains Approval Expansion for Excimer Laser Treatments | SSKN Stock News
Strata Skin Sciences AMA accepted revision to CPT codes